Article
Treatment of Huntington’s disease with a pan-HTT-targeting CRISPR nuclease
2025-12-22
Abstract excerpt
<h4>ABSTRACT</h4> Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by an expansion of a CAG trinucleotide repeat in the huntingtin (HTT) gene, which leads to a mutant protein that destroys neurons in the brain. Despite intense effort, there remains no approved disease-modifying therapy for HD. Here we develop a pan-HTT-targeting CRISPR-Cas9 system that, when delivered to the striatum of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c71b4dfc-d500-5663-b829-9c6f3e27dc85
- DOI
- 10.64898/2025.12.20.695720
